Last reviewed · How we verify
CNTO 95 and avastin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
CNTO 95 and avastin (CNTO 95 and avastin) — Herbert Hurwitz, MD.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CNTO 95 and avastin TARGET | CNTO 95 and avastin | Herbert Hurwitz, MD | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CNTO 95 and avastin CI watch — RSS
- CNTO 95 and avastin CI watch — Atom
- CNTO 95 and avastin CI watch — JSON
- CNTO 95 and avastin alone — RSS
Cite this brief
Drug Landscape (2026). CNTO 95 and avastin — Competitive Intelligence Brief. https://druglandscape.com/ci/cnto-95-and-avastin. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab